Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NPRL2 encodes a protein that is an essential catalytic component of the GATOR1 complex. The primary function of this complex is to inhibit the amino acid-sensing branch of the mTORC1 pathway. In response to amino acid depletion, GATOR1 acts as a GTPase activating protein (GAP) for RagA/B within heterodimeric Rag complexes. Loss or mutation in NPRL2 is associated with Familial Focal Epilepsy With Variable Foci and increased cancer risk. It functions as a tumor suppressor.
Acts as a GTPase activating protein (GAP) for RagA/B, inhibiting mTORC1 signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrogen permease regulator-like 2 protein (NPRL2).